U.S. Biotech Stock News

If you are wondering whether Old Dominion Freight Line is priced fairly or if the current level offers value, you are in the right place because this article focuses squarely on what the numbers say about the stock. The share price recently closed at US$209.50, with returns of 5.8% over 7 days, 7.4% over 30 days, 31.6% year to date and 34.6% over the past year. These figures give useful context before looking at what that price might imply about value. Recent coverage has focused on Old...

Wondering if Marriott Vacations Worldwide at around US$68.50 is offering value or just looks cheap on the surface? This article walks through what the current price might really mean for you. The stock has returned 1.6% over the last 7 days, 2.9% over the last 30 days, 16.4% year to date and 36.0% over the last year, but those gains sit alongside a 43.1% decline over 3 years and a 54.7% decline over 5 years. These mixed returns have put more attention on what is driving sentiment around the...

Trip.com Group (NasdaqGS:TCOM) is back in focus after Chinese regulators launched an antitrust investigation into its alleged monopolistic practices, particularly an AI pricing tool, prompting multiple securities class action lawsuits and renewed attention to regulatory risk. See our latest analysis for Trip.com Group. The antitrust probe and subsequent class action filings have coincided with a sharp 90 day share price return of negative 32.14% and a year to date share price return of...

Costco Wholesale recently reported that net sales for March 2026 rose to US$28.41 billion, up 11.3% year over year, with comparable sales and e-commerce growing across US, Canada, and international markets despite one fewer shopping day due to the Easter calendar shift. Ancillary categories such as gasoline, pharmacy, and food courts, combined with more than 20% growth in digital sales, underscored how Costco’s value-focused model is pulling in higher traffic and larger baskets across both...

If you are wondering whether D.R. Horton is fairly priced or offering value at current levels, this breakdown will help you put the recent share price in context. The stock last closed at US$143.74, with recent returns of 2.9% over 7 days, a 1.1% decline over 30 days, a 1.4% decline year to date, and gains of 23.4% over 1 year, 51.1% over 3 years, and 62.4% over 5 years. Recent coverage around US homebuilding and housing supply has kept attention on the sector, as investors look at how...

If you are asking whether STAAR Surgical's current share price lines up with its underlying worth, the recent moves in the stock make that question especially timely. The shares last closed at US$25.21, with returns of 24.7% over the past week, 46.3% over the past month, 6.8% year to date, and 61.9% over one year, set against declines of 62.5% over three years and 79.0% over five years. This mix of strong shorter term returns and weaker longer term results means recent news and changing...

Wondering if Lincoln Electric Holdings at around US$256 per share still offers value after a strong run, or if expectations are already baked into the price. The stock currently trades at US$256.11, with returns of 5.1% over the last week, a 3.6% decline over the past month, 5.1% year to date, 46.7% over one year, 67.3% over three years and 124.2% over five years, which may catch your eye if you focus on long term performance and recent volatility. Recent coverage has focused on Lincoln...

Recent share performance and business mix Leidos Holdings (LDOS) has seen its share price retreat recently, with a 3.1% decline over the past day, around 2% over the past week, and close to 10% over the past month. That shorter term weakness follows a larger past 3 months pullback of roughly 21.5% and a year to date decline of about 15.2%, even as the 1 year total return remains positive at 12.5%. Behind the stock is a sizeable government and commercial services business, generating US$17.2b...

Why Ouster’s latest guidance has investors watching the next earnings call Ouster (OUST) has drawn fresh attention after management issued first quarter 2026 revenue guidance of US$45 million to US$48 million, above analyst expectations and incorporating the recent StereoLabs acquisition. This update, combined with twelve consecutive quarters of product revenue increases and higher software attached bookings in 2025, has put extra focus on the upcoming earnings report as investors look for...

Recent analyst commentary on Avery Dennison (AVY) has focused on weak consumer demand, rising costs, and sector headwinds, with some market participants highlighting the possibility of muted growth and a greater role for M&A in the year ahead. See our latest analysis for Avery Dennison. At a share price of US$173.81, Avery Dennison has a 1 year total shareholder return of 6.6%, but a 90 day share price return of a 7.7% decline signals fading momentum despite modest longer term gains. If you...

Analyst upgrade puts PJT Partners (PJT) back in focus PJT Partners (PJT) moved into the spotlight after Keefe, Bruyette & Woods shifted its rating to Outperform, highlighting the firm’s exposure to large cap and complex M&A advice as a key factor. See our latest analysis for PJT Partners. At a US$150.00 share price, PJT Partners has recently seen a 7.15% 7 day share price return and a 7.43% 30 day share price return. The 1 year total shareholder return of 16.68% sits against weaker year to...

The latest catalyst around Texas Instruments (TXN) is a high profile analyst upgrade to Buy, tied to stronger free cash flow, margin improvement, and expectations for an analog semiconductor upcycle. See our latest analysis for Texas Instruments. That upgrade has landed at a time when momentum is already strong, with the share price at US$214.98, a 21.1% year to date share price return and a 50.25% 1 year total shareholder return. This suggests improving sentiment toward TXN’s longer term...

Wondering if CVS Health at around US$78.84 is giving you fair value for the risk you are taking, or if the current price is leaving something on the table? The stock has a 7.3% return over the past 7 days and 3.3% over the last month, while the year to date return sits at a 1.6% decline and the 1 year return is 18.7%. Recent headlines have focused on CVS Health's positioning as a major integrated healthcare player and its ongoing efforts to balance its retail, pharmacy benefit, and health...

Conagra Brands (NYSE:CAG) is expanding its frozen portfolio with new high protein breakfast themed meals aimed at lunch and other non morning eating occasions. Recent launches include mini Tennessee Pride breakfast sandwiches and Banquet Mega breakfast bowls positioned for all day consumption. The move targets consumers who are increasingly eating traditional breakfast foods beyond the morning meal. For anyone tracking packaged food companies, this is a clear sign that Conagra Brands, the...

Price hikes in EMEA put Sonoco Products in focus Sonoco Products (SON) has moved to raise prices across key industrial packaging categories in Europe, the Middle East and Africa, responding to higher costs for energy, fuel and raw materials. See our latest analysis for Sonoco Products. The price increases in EMEA arrive at a time when Sonoco Products’ share price has built momentum, with a 30 day share price return of 5.24% and a 90 day gain of 18.44%. The 1 year total shareholder return...

If you are wondering whether ATI is offering value at today's price or if the story has already played out, this breakdown will help you frame what the current share price could mean for you. ATI closed at US$159.63, with returns of 8.9% over 7 days, 0.4% over 30 days, 33.9% year to date, 244.2% over 1 year and 308.8% over 3 years, while the 5 year return is about 7 times the starting point. Recent coverage around ATI has focused on how its share price performance compares with peers in the...

If you are wondering whether Antero Midstream’s share price still offers value at around US$22.21, you are not alone, many investors are asking the same question right now. The stock has had a mixed recent run, with a 2.4% decline over the last week and a 1.7% decline over the last month, yet it is still up 23.8% year to date and 47.2% over the past year. Those moves have put valuation under the spotlight again, as investors weigh up Antero Midstream’s role within the broader energy...

Mercury Insurance, part of Mercury General (NYSE:MCY), is promoting safe driving practices tied to spring rain conditions. The company is also sharing guidance during Distracted Driving Awareness Month to encourage more attentive driving. These initiatives focus on public safety messaging for policyholders and drivers more broadly. For a property and casualty insurer such as Mercury General, road safety is core to both customer outcomes and claims experience. By spotlighting the hazards of...

Earlier this month, Molina Healthcare reacted to the Centers for Medicare & Medicaid Services’ finalized 2027 Medicare Advantage payment rates, which lifted reimbursement levels across the industry and prompted the company to schedule an earnings call and investor day focused on valuation and margins. The news also drew attention to Molina’s heavy reliance on Medicaid and Medicare in large states such as California, New York, Texas, and Washington, where payment policy and cost trends can...

Adobe is confronting intensified AI-focused competition, a planned CEO transition with Shantanu Narayen set to step down, and fresh regulatory scrutiny tied to a major subscription settlement. At the same time, the company reports record AI-related revenue and AI first ARR growth, while rolling out new AI features for education customers. These parallel developments are reshaping the risk and opportunity profile for NasdaqGS:ADBE and drawing heightened investor attention. For investors...

Firmer analyst sentiment and rising earnings expectations have pushed Northern Trust (NTRS) into focus, as recent upgrades and consistent estimate beats shape how investors assess the bank’s wealth and asset management centered model. See our latest analysis for Northern Trust. At a share price of US$152.63, Northern Trust has seen a 7.30% 7 day share price return and a 10.62% 30 day share price return. Its 1 year total shareholder return of 77.93% shows that recent momentum has built on a...

If you are wondering whether Wells Fargo is attractively priced today or if the recent run leaves it in stretched territory, this breakdown will help you frame where value might actually sit. Wells Fargo shares last closed at US$86.02, with returns of 6.7% over 7 days, 9.9% over 30 days, a 9.6% decline year to date, and 39.3% over 1 year and 134.2% over 3 years, so recent moves have been far from quiet. Headlines around large U.S. banks, regulatory scrutiny and sector-wide shifts in capital...

In recent days, RBC Capital reiterated a bearish view on Pfizer, highlighting competitive and pricing pressures on key products including Paxlovid, Vyndamax, and Prevnar, alongside expectations for a year-over-year revenue decline. This renewed skepticism arrives as Pfizer pursues an extensive pipeline and acquisition program, sharpening the contrast between near-term product headwinds and longer-term portfolio ambitions. Against this backdrop, we’ll examine how RBC’s continued caution on...

If you are wondering whether Lockheed Martin is still fairly priced after a strong run, or if the stock is starting to look stretched, this article walks through the key numbers so you can judge the value for yourself. The stock last closed at US$623.87, with returns of 0.2% over the past week, a 4.2% decline over the past month, 25.5% year to date and 38.2% over the last year. Recent headlines have focused on Lockheed Martin's role in defense contracts and broader sector sentiment, which...